B Braun Medical Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for B BRAUN MEDICAL INC, and when can generic versions of B BRAUN MEDICAL INC drugs launch?
B BRAUN MEDICAL INC has eleven approved drugs.
There are two US patents protecting B BRAUN MEDICAL INC drugs.
There are twenty-seven patent family members on B BRAUN MEDICAL INC drugs in twenty-seven countries and fifty-nine supplementary protection certificates in fifteen countries.
Summary for B Braun Medical Inc
| International Patents: | 27 |
| US Patents: | 2 |
| Tradenames: | 11 |
| Ingredients: | 10 |
| NDAs: | 11 |
| Drug Master File Entries: | 21 |
Drugs and US Patents for B Braun Medical Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B Braun Medical Inc | MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER | meropenem | POWDER;INTRAVENOUS | 202106-002 | Apr 30, 2015 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| B Braun Medical Inc | CLOROTEKAL | chloroprocaine hydrochloride | SOLUTION;INTRATHECAL | 208791-001 | Sep 26, 2017 | DISCN | Yes | No | 9,504,666 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| B Braun Medical Inc | CALCIUM GLUCONATE | calcium gluconate | SOLUTION;INTRAVENOUS | 216541-001 | Aug 21, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| B Braun Medical Inc | ACETAMINOPHEN | acetaminophen | SOLUTION;INTRAVENOUS | 204957-001 | Feb 18, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| B Braun Medical Inc | MAGNESIUM SULFATE | magnesium sulfate | INJECTABLE;INJECTION | 207967-002 | Apr 26, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| B Braun Medical Inc | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 208827-001 | Nov 19, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| B Braun Medical Inc | LEVETIRACETAM IN SODIUM CHLORIDE | levetiracetam | INJECTABLE;INTRAVENOUS | 209705-001 | Feb 27, 2024 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for B Braun Medical Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 1931304 | ⤷ Try a Trial |
| Italy | MI20122120 | ⤷ Try a Trial |
| South Korea | 102162587 | ⤷ Try a Trial |
| Malaysia | 180957 | ⤷ Try a Trial |
| South Korea | 20150085131 | ⤷ Try a Trial |
| China | 105283222 | ⤷ Try a Trial |
| Slovenia | 1931304 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for B Braun Medical Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2957286 | C02957286/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: PATIROMER SORBITEX CALCIUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66411 22.12.2017 |
| 0521471 | SPC/GB03/033 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321 |
| 0984957 | CR 2012 00035 | Denmark | ⤷ Try a Trial | PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105 |
| 0984957 | 122012000017 | Germany | ⤷ Try a Trial | PRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812 |
| 2603514 | CA 2019 00015 | Denmark | ⤷ Try a Trial | PRODUCT NAME: EN KOMBINATION AF VABORBACTAM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, OG MEROPENEM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, SAERLIGT MEROPENEM TRIHYDRAT; REG. NO/DATE: EU/1/18/1334 20181122 |
| 2603514 | 19C1021 | France | ⤷ Try a Trial | PRODUCT NAME: COMBINAISON DE VABORBACTAME, ET/OU D'UN SEL ET/OU D'UN HYDRATE DE CELUI-CI, ET DE MEROPENEME, ET/OU D'UN SEL ET/OU D'UN HYDRATE DE CELUI-CI, EN PARTICULIER DE MEROPENEME TRIHYDRATE; REGISTRATION NO/DATE: EU/1/18/1334 20181122 |
| 1020461 | 300482 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMZOUT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
